J. Boudreau
Chief Executive Officer bei Radcliffe Consulting & Investment Ltd.
Vermögen: 30 800 $ am 31.03.2024
Profil
J.
Bernard Boudreau is currently the President & Chief Executive Officer at Radcliffe Consulting & Investment Ltd.
and a Director at Intelgenx Corp.
He previously served as Vice Chairman at IntelGenx Technologies Corp.
from 2014 to 2023, Director at Export Development Canada, Director at The Bank of Canada, Director at Pillar5 Pharma, Inc. from 2010 to 2013, and Vice President at PharmEng International, Inc. from 2005 to 2008.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
13.03.2023 | 175 000 ( 0,10% ) | 30 800 $ | 31.03.2024 |
Aktive Positionen von J. Boudreau
Unternehmen | Position | Beginn |
---|---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Director/Board Member | 01.06.2006 |
Radcliffe Consulting & Investment Ltd. | Chief Executive Officer | 28.07.2011 |
Ehemalige bekannte Positionen von J. Boudreau
Unternehmen | Position | Ende |
---|---|---|
INTELGENX TECHNOLOGIES CORP. | Director/Board Member | 21.07.2023 |
Pillar5 Pharma, Inc.
Pillar5 Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pillar5 Pharma, Inc. develops, researches and manufactures sterile opthalmic and solid dose. It offers solid dose manufacturing, solid dose packaging, analytical and microbiological testing, and formulation and process development services. The company was founded in 2009 and is headquartered in Arnprior, ON. | Director/Board Member | 01.01.2013 |
Export Development Canada
Export Development Canada Finance/Rental/LeasingFinance Export Development Canada engages in the provision of insurance and financial services. It offers bond products, financing, insurance, and risk management solutions to help Canadian exporters and investors expand their international business. The company was founded in 1944 and is headquartered in Ottawa, Canada. | Director/Board Member | 01.09.2008 |
PharmEng International, Inc.
PharmEng International, Inc. Miscellaneous Commercial ServicesCommercial Services PharmEng International, Inc. was a full-service consulting and contract manufacturing company, which serves the pharmaceutical and biotechnology industries. The company was founded on October 1, 2003 and was headquartered in Markham, ON. | Corporate Officer/Principal | 01.01.2008 |
The Bank of Canada
The Bank of Canada General GovernmentGovernment The Bank of Canada provides banking and financial services. Its services include mortgage and payment processing, loan application, credit card application, accounting solutions, tax preparation, financial analysis, insurance, and payroll processing services to its clients. The company was founded in 1934 and is headquartered in Ottawa, Canada. | Director/Board Member | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INTELGENX TECHNOLOGIES CORP. | Health Technology |
Private Unternehmen | 6 |
---|---|
Export Development Canada
Export Development Canada Finance/Rental/LeasingFinance Export Development Canada engages in the provision of insurance and financial services. It offers bond products, financing, insurance, and risk management solutions to help Canadian exporters and investors expand their international business. The company was founded in 1944 and is headquartered in Ottawa, Canada. | Finance |
PharmEng International, Inc.
PharmEng International, Inc. Miscellaneous Commercial ServicesCommercial Services PharmEng International, Inc. was a full-service consulting and contract manufacturing company, which serves the pharmaceutical and biotechnology industries. The company was founded on October 1, 2003 and was headquartered in Markham, ON. | Commercial Services |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
The Bank of Canada
The Bank of Canada General GovernmentGovernment The Bank of Canada provides banking and financial services. Its services include mortgage and payment processing, loan application, credit card application, accounting solutions, tax preparation, financial analysis, insurance, and payroll processing services to its clients. The company was founded in 1934 and is headquartered in Ottawa, Canada. | Government |
Pillar5 Pharma, Inc.
Pillar5 Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pillar5 Pharma, Inc. develops, researches and manufactures sterile opthalmic and solid dose. It offers solid dose manufacturing, solid dose packaging, analytical and microbiological testing, and formulation and process development services. The company was founded in 2009 and is headquartered in Arnprior, ON. | Health Technology |
Radcliffe Consulting & Investment Ltd. |